Schalken J - Search Results

1

Genomic Predictors of Outcome in Prostate Cancer.

Boström PJ, Bjartell AS, Catto JW, Eggener SE, Lilja H, Loeb S, Schalken J, Schlomm T, Cooperberg MR. Boström PJ, et al. Among authors: schalken j. Eur Urol. 2015 Dec;68(6):1033-44. doi: 10.1016/j.eururo.2015.04.008. Epub 2015 Apr 23. Eur Urol. 2015. PMID: 25913390 Free article. Review.

2

Identification of new prostate cancer progression markers by differential hybridization analysis.

Schalken JA, Debruyne FM. Schalken JA, et al. Eur Urol. 1992;21 Suppl 1:60-5. doi: 10.1159/000474893. Eur Urol. 1992. PMID: 1425840 Review.

3

Quantitative light microscopy in urological oncology.

van der Poel HG, Schaafsma HE, Vooijs GP, Debruyne FM, Schalken JA. van der Poel HG, et al. Among authors: schalken ja. J Urol. 1992 Jul;148(1):1-13. doi: 10.1016/s0022-5347(17)36494-7. J Urol. 1992. PMID: 1613843 Review. No abstract available.

4

Cytotoxic effects of high energy shock waves in different in vitro models: influence of the experimental set-up.

Smits GA, Oosterhof GO, de Ruyter AE, Schalken JA, Debruyne FM. Smits GA, et al. Among authors: schalken ja. J Urol. 1991 Jan;145(1):171-5. doi: 10.1016/s0022-5347(17)38284-8. J Urol. 1991. PMID: 1984086

5

Oncogene expression in prostate cancer.

Schalken JA, Bussemakers MJ, Debruyne FM. Schalken JA, et al. Prog Clin Biol Res. 1990;357:97-105. Prog Clin Biol Res. 1990. PMID: 2217484 Review.

6

The Heinrich Warner Prize 1989: the use of differential hybridization analysis to identify markers for diagnosis of urogenital cancer.

Schalken JA. Schalken JA. Eur Urol. 1990;18 Suppl 2:52-7. doi: 10.1159/000463965. Eur Urol. 1990. PMID: 2226612 Review. No abstract available.

7

In vivo effects of high energy shock waves on urological tumors: an evaluation of treatment modalities.

Oosterhof GO, Smits GA, de Ruyter AE, Schalken JA, Debruyne FM. Oosterhof GO, et al. Among authors: schalken ja. J Urol. 1990 Sep;144(3):785-9. doi: 10.1016/s0022-5347(17)39592-7. J Urol. 1990. PMID: 2388350

8

Expression of markers for transitional cell carcinoma in normal bladder mucosa of patients with bladder cancer.

Witjes JA, Umbas R, Debruyne FM, Schalken JA. Witjes JA, et al. Among authors: schalken ja. J Urol. 1995 Dec;154(6):2185-9. J Urol. 1995. PMID: 7500486

9

Characterization of human prostate cancer, benign prostatic hyperplasia and normal prostate by in vitro 1H and 31P magnetic resonance spectroscopy.

Cornel EB, Smits GA, Oosterhof GO, Karthaus HF, Deburyne FM, Schalken JA, Heerschap A. Cornel EB, et al. Among authors: schalken ja. J Urol. 1993 Dec;150(6):2019-24. doi: 10.1016/s0022-5347(17)35957-8. J Urol. 1993. PMID: 7693985

10

Cytogenetics of prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.

Debruyne FM, Collins VP, van Dekken H, Jenkins RB, Klocker H, Schalken JA, Sesterhenn IA. Debruyne FM, et al. Among authors: schalken ja. Scand J Urol Nephrol Suppl. 1994;162:65-71; discussion 115-27. Scand J Urol Nephrol Suppl. 1994. PMID: 7817161 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

445 results

Search Page